A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 Inhibitors
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
- Status
- UNKNOWN
- Phase
- N/A
Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea
- Status
- COMPLETED
- Phase
- N/A
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
- Status
- UNKNOWN
- Phase
- PHASE4
Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Utility of FES F18 PET/CT in Metastatic Breast Cancer Patients
- Status
- TERMINATED
- Phase
- N/A
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies
- Status
- COMPLETED
- Phase
- N/A
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Tenalisib (RP6530), in Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Real World Tumor Response in Pre-menopausal Metastatic Breast Cancer Patients Treated With Palbociclib + Aromatase Inhibitor or Aromatase Inhibitor Alone
- Status
- COMPLETED
- Phase
- N/A
Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET
- Status
- COMPLETED
- Phase
- N/A
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Scalp Cooling in MBC
- Status
- RECRUITING
- Phase
- PHASE2